Published in Sci Rep on November 12, 2015
Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects. Lung Cancer (Auckl) (2017) 0.77
Odor-Sensing System to Support Social Participation of People Suffering from Incontinence. Sensors (Basel) (2016) 0.75
Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples. J Infect (2016) 0.75
An Exploration of the Metal Dependent Selectivity of a Metalloporphyrins Coated Quartz Microbalances Array. Sensors (Basel) (2016) 0.75
Screening of Obstructive Sleep Apnea Syndrome by Electronic-Nose Analysis of Volatile Organic Compounds. Sci Rep (2017) 0.75
Structure and chemistry of cytochrome P450. Chem Rev (2005) 5.85
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70
Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol (2009) 3.16
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron (2003) 2.72
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer (2010) 2.35
An investigation on electronic nose diagnosis of lung cancer. Lung Cancer (2009) 1.85
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer (2008) 1.80
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res (2005) 1.68
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54
Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev (2012) 1.54
A review of the volatiles from the healthy human body. J Breath Res (2014) 1.46
Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. Small (2009) 1.33
Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J Chromatogr (1988) 1.28
Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat (2006) 1.26
Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev (2013) 1.23
Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta (2008) 1.21
Artificial noses. Annu Rev Biomed Eng (2011) 1.21
Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol (2012) 1.19
Solid-state gas sensors for breath analysis: a review. Anal Chim Acta (2014) 1.18
Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine (2011) 1.16
Classification of breast cancer precursors through exhaled breath. Breast Cancer Res Treat (2010) 1.12
A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine (2012) 1.09
Effects of ventilation on the collection of exhaled breath in humans. J Appl Physiol (1985) (2003) 0.98
Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study. Br J Cancer (2014) 0.94
Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. Analyst (2013) 0.90
Combined volatolomics for monitoring of human body chemistry. Sci Rep (2014) 0.87
Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. BMC Pulm Med (2014) 0.85
Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Sci Rep (2014) 0.85
Breath analysis during one-lung ventilation in cancer patients. Eur Respir J (2012) 0.84
In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling. Lung Cancer (2012) 0.84
Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.82
Dead space: the physiology of wasted ventilation. Eur Respir J (2014) 0.79